Home Policy Areas SAMHSA Extends OTP Exemption for In-Person Physical Exam for Buprenorphine Treatment
SAMHSA Extends OTP Exemption for In-Person Physical Exam for Buprenorphine Treatment
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced today it is extending its opioid treatment program (OTP) exemption for an in-person physical evaluation for buprenorphine treatment for a period of one year from the end of the COVID-19 Public Health Emergency (PHE). The extension goes into effect upon the expiration of the COVID-19 PHE.
